IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Sai Parenteral's Ltd.
Issue Open Date 24-Mar-26  
Issue Closing Date 27-Mar-26  
Application Money 100  
Allotment Money  
Price Band 372 - 392  
Minimium Application No. 38  
Issue Size (Shares) 7522486  
Market Lot 1.00  
Objective
1. Capacity expansion and upgradation of manufacturing facilities; 2. Establishment of a new R&D Centre; 3. Repayment / prepayment of certain outstanding borrowings; 4. Working capital requirements; 5. Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia); and 6. General corporate purposes
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1622876   3831502   2.36  
Qualified Institutional Buyers   2112900   3610266   1.71  
Retail Individual Investors   3786710   439204   0.12  
Business Description
Our Company is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing. We are in the business of (i) Branded Generic Formulations and (ii) Contract Development and Manufacturing Organisation (“CDMO”) prod
more...
Promoter's Holding
Total Share Capital   22600001  
Offered to Public   7522486  
Promoter's Holding (Pre-Issue)   61.23  
Promoter's Holding (Post-Issue)   51.1553  
Address
Plot No.39
5th Floor
Lavanya Arcade
Jayabheri Enclave
Gachibowli
K. V
Seri Lingampally
Rangareddy ,
Telangana ,
500032
Phone: 7997991301
Email: cs@saiparenterals.com
Website: www.saiparenterals.com
Registrar
Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
Arihant Capital Markets Ltd.
Promoters
Anil Kumar Karusala
Karusala Aruna
Vijitha Gorrepati
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.